172 related articles for article (PubMed ID: 36125485)
1. Roflumilast for Chronic Plaque Psoriasis.
Cordoro KM
JAMA; 2022 Sep; 328(11):1049-1050. PubMed ID: 36125485
[No Abstract] [Full Text] [Related]
2. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis.
Smith B; Collier MR; Wu JJ
JAMA; 2023 Feb; 329(7):594-595. PubMed ID: 36809326
[No Abstract] [Full Text] [Related]
3. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-Reply.
Lebwohl MG; Hebert AA; Gooderham MJ
JAMA; 2023 Feb; 329(7):595. PubMed ID: 36809324
[No Abstract] [Full Text] [Related]
4. Treating 2 Diseases With 1 Drug: PDE-4 Inhibitor for COPD and Psoriasis.
Michels K; Hagner M; El Zein M; Dasa O; Assaly R
Am J Ther; 2017; 24(1):e103-e104. PubMed ID: 27415981
[No Abstract] [Full Text] [Related]
5. Roflumilast (Daliresp) for COPD.
Med Lett Drugs Ther; 2011 Jul; 53(1369):59-60. PubMed ID: 21778965
[No Abstract] [Full Text] [Related]
6. Roflumilast for asthma: Weighing the evidence.
Bateman ED; O'Byrne PM; Buhl R; Rabe KF
Pulm Pharmacol Ther; 2015 Dec; 35 Suppl():S1-3. PubMed ID: 26278190
[No Abstract] [Full Text] [Related]
7. What is the role of roflumilast in chronic obstructive pulmonary disease?
Lau C; Mehta AC; Hatipoglu U
Cleve Clin J Med; 2017 Jan; 84(1):13-15. PubMed ID: 28084977
[No Abstract] [Full Text] [Related]
8. Clinical Question: In adults with COPD does roflumilast reduce the frequency of exacerbations compDared to standard therapies aIone?
Huser JM; Hodgden JD
J Okla State Med Assoc; 2016 Feb; 109(2):59-60. PubMed ID: 27169222
[No Abstract] [Full Text] [Related]
9. Reduce disease burden and improve lung function-roflumilast: approved for moderate to severe COPD: update for the clinical nurse specialist.
O'Malley P
Clin Nurse Spec; 2011; 25(4):176-7. PubMed ID: 21654371
[No Abstract] [Full Text] [Related]
10. Roflumilast: clinical benefit in patients suffering from COPD.
Ulrik CS; Calverley PM
Clin Respir J; 2010 Oct; 4(4):197-201. PubMed ID: 20887341
[TBL] [Abstract][Full Text] [Related]
11. Alternatives to indicating roflumilast and the chronic obstructive pulmonary disease classification.
Blasco LM
Arch Bronconeumol; 2012 Sep; 48(9):343. PubMed ID: 22503591
[No Abstract] [Full Text] [Related]
12. [Phosphodiesterase-4 inhibitors: roflumilast].
Izquierdo Alonso JL
Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
[TBL] [Abstract][Full Text] [Related]
13. An update on topical therapies for psoriasis.
Pender EK; Kirby B
Curr Opin Rheumatol; 2024 Jul; 36(4):289-294. PubMed ID: 38651512
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap.
Zhang X; Chen Y; Fan L; Ye J; Fan J; Xu X; You D; Liu S; Chen X; Luo P
Drug Des Devel Ther; 2018; 12():2371-2379. PubMed ID: 30122895
[TBL] [Abstract][Full Text] [Related]
15. Randomized Double-Blind Controlled Trial of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Mackay AJ; Patel ARC; Singh R; Sapsford RJ; Donaldson GC; Prasad N; Goehring UM; Nip TK; Wedzicha JA
Am J Respir Crit Care Med; 2017 Sep; 196(5):656-659. PubMed ID: 28146642
[No Abstract] [Full Text] [Related]
16. [Roflumilast: clinical review of a new option for the treatment of inflammation in COPD].
Martínez FJ
Arch Bronconeumol; 2010 Nov; 46 Suppl 9():8-11. PubMed ID: 21320811
[No Abstract] [Full Text] [Related]
17. Roflumilast for severe COPD?
Drug Ther Bull; 2011 Apr; 49(4):45-8; quiz iii-iv. PubMed ID: 21467576
[TBL] [Abstract][Full Text] [Related]
18. The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease.
Wedzicha JA
Pol Arch Med Wewn; 2010; 120(1-2):9-10. PubMed ID: 20150838
[No Abstract] [Full Text] [Related]
19. The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients.
De Backer W; Vos W; Van Holsbeke C; Vinchurkar S; Claes R; Hufkens A; Parizel PM; Bedert L; De Backer J
Eur Respir J; 2014 Aug; 44(2):527-9. PubMed ID: 24791831
[No Abstract] [Full Text] [Related]
20. [Phosphodiesterase-4 inhibitors: a new target in treatment of COPD].
Michels G; Erdmann E; Pfister R
Dtsch Med Wochenschr; 2011 Nov; 136(44):2267-70. PubMed ID: 22028292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
